Biopredictive Dissolutions for Conventional IR, MR and Non-Oral Formulations–Current Status and Future Opportunities

S Mondal, S Kollipara, M Chougule, A Bhatia… - Journal of Drug Delivery …, 2024 - Elsevier
Over the past few decades, biopredictive dissolution coupled with physiologically based
biopharmaceutics modeling (PBBM) has gained significance due to its ability to predict in …

Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration

J Djuris, S Cvijic, L Djekic - Pharmaceuticals, 2024 - mdpi.com
The pharmaceutical industry has faced significant changes in recent years, primarily
influenced by regulatory standards, market competition, and the need to accelerate drug …

Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of …

Y Tsume, L Ashworth, M Bermejo Sanz… - Molecular …, 2024 - ACS Publications
Biorelevant dissolution and its concept have been widely accepted and further developed to
meaningfully predict the bioperformance of oral drug products. Biorelevant methodologies …

Compare and PASS− Fast screening of oral dosage forms for bioequivalence probability with the COMPASS software

D Danielak, D Myslitska, M Winiarski… - International Journal of …, 2025 - Elsevier
COMPASS is a novel tool for predicting the in vivo similarity of immediate-release oral
dosage forms. It bridges the gap between straightforward but purely mathematical f2 factor …

Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus

Y Guo, A Byer-Alcorace, C Thomas, S Piekos… - Journal of …, 2024 - Elsevier
In this work, the ability of the artificial stomach and duodenum (ASD) model to predict
bioavailability in rats was investigated using a poorly soluble model compound, BI-639667 …